x
English
My account

Trade Nic Nanovect - NANOo CFD

1m
5m
15m
30m
1H
4H
1D
1W

Trader sentiment

% Buyers % Sellers
  • Long position overnight fee -0.0187%
  • Short position overnight fee -0.0091%
  • Overnight fee time 22:00 (UTC)
  • Min traded quantity 1
  • Currency NOK
  • Margin 20%
  • Stock exchange Norway
  • Trading hours (UTC)
    Mon - Fri: 08:01 - 15:15
  • Commission on trade 0%

Open a trading account in less than 3 min

Open Now
Nordic Nanovector ASA is a Norway-based company active in the biotechnology industry. It is engaged in the development and commercialisation of targeted therapeutics for haematological cancers. Its main product candidate is Betalutin, a tumor-seeking anti-CD37 antibody conjugated to a low intensity radionuclide (Lutetium 177). It is designed to improve the treatment of Non-Hodgkin Lymphoma (NHL) and has advanced through clinical development. The company has a collaboration agreement with AREVA Med and Paul Scherrer Institute to develop antibody-drug conjugates for treating various types of leukaemia; and LegoChem Biosciences and Heidelberg Pharma to develop Antibody Radionuclide conjugates. The company was formerly known as Nordic Nanovector AS, but changed its name to Nordic Nanovector ASA in 2014. Nordic Nanovector ASA was founded in 2009 and is headquartered in Oslo, Norway. Capital.com enables you to browse the Nordic Nanovector (NANO) share price in real time.
Learn more Hide

How we make money?

Capital.com makes the majority of it’s money through the spread, the difference between the buy and sell price.

Trade shares with leverage

Shares are available to trade with up to 5:1 leverage. Start trading with as little as $100 to control a position of $500

Shares CFDs

  • Trade 24/5 on a wide range of shares

  • Buy and sell shares to take advantage of rises and falls in price

Profit and loss control

You can easily define Stops and Limits to request positions to close at a specified price.

Set up price alerts to be informed of big moves.

You might be interested in